Dr. Steven J Deeks, MD
Claim this profileSan Francisco General Hospital
Studies Human Immunodeficiency Virus Infection
Studies HIV Infection
12 reported clinical trials
15 drugs studied
Affiliated Hospitals
Clinical Trials Steven J Deeks, MD is currently running
Leukapheresis
for HIV/AIDS
Despite the dramatic improvements that have resulted from combination antiretroviral treatment, long-term efficacy, toxicity, cost, and the requirements for life-long adherence remain as formidable challenges. Also, there is emerging consensus that persistent HIV-associated disease occurs during long-term highly active antiretroviral therapy (HAART). This disease may be due to either direct drug-toxicity and/or persistent viral replication/production and/or persistent HIV-associated inflammation. Hence, strategies aimed at achieving complete viral eradication may be needed in order to fully restore health among HIV infected individuals. Even if complete eradication proves impossible-as most believe to be the case-a less rigorous but still desirable outcome might be achieving durable control of virus in the absence of therapy. That a "functional" cure is possible is well illustrated by those rare individuals who are able to durably control replication competent virus in the absence of therapy ("elite" controllers). A more complete understanding of the relationship between inflammation and viral persistence is necessary before more rationale studies of HIV eradication can be designed. Also, a well validated high through-put virologic assay needs to be developed that can estimate the size of the latent reservoir. Since the level of replication competent virus in long-term treated patients (and in elite controllers) is very small (\< 1% of CD4 cells harbor HIV), large numbers of CD4+ T cells most be obtained from study participants in order to routinely isolate and quantify virus persistence.
Recruiting1 award N/A4 criteria
PET-MR Imaging with [18F]F-AraG
for HIV Infection
This is a single center exploratory imaging study involving one intravenous microdose of \[18F\]F-AraG followed by whole-body positron emission tomography-magnetic resonance (PET-MR) imaging in HIV infected individuals to determine the anatomical distribution of the PET tracer. Participants will be enrolled if they were treated during early or late HIV infection. In addition, individuals not on antiretroviral therapy (ART) or with HIV-1 plasma RNA levels \>5,000 copies/mL will be enrolled. Up to 30 participants will be enrolled with HIV.
Recruiting1 award Phase 2
More about Steven J Deeks, MD
Clinical Trial Related4 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Steven J Deeks, MD has experience with
- Placebo
- Cyclophosphamide
- LVgp120duoCAR-T Cells, High Dose
- LVgp120duoCAR-T Cells, Low Dose
- Treatment Interruption Arm
- [18F]F-AraG
Breakdown of trials Steven J Deeks, MD has run
Human Immunodeficiency Virus Infection
HIV Infection
AIDS
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Steven J Deeks, MD specialize in?
Steven J Deeks, MD focuses on Human Immunodeficiency Virus Infection and HIV Infection. In particular, much of their work with Human Immunodeficiency Virus Infection has involved treating patients, or patients who are undergoing treatment.
Is Steven J Deeks, MD currently recruiting for clinical trials?
Yes, Steven J Deeks, MD is currently recruiting for 7 clinical trials in San Francisco California. If you're interested in participating, you should apply.
Are there any treatments that Steven J Deeks, MD has studied deeply?
Yes, Steven J Deeks, MD has studied treatments such as Placebo, Cyclophosphamide, LVgp120duoCAR-T cells, high dose.
What is the best way to schedule an appointment with Steven J Deeks, MD?
Apply for one of the trials that Steven J Deeks, MD is conducting.
What is the office address of Steven J Deeks, MD?
The office of Steven J Deeks, MD is located at: San Francisco General Hospital, San Francisco, California 94110 United States. This is the address for their practice at the San Francisco General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.